John Mendlein insider trades

Open-market stock purchases and sales by John Mendlein, Unknown at Fate Therapeutics Inc, from SEC Form 4 filings since Oct 4, 2013.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -65%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • FATE Fate Therapeutics Inc: 3 buys, 3 sales, last May 29, 2025
  • OMGA Omega Therapeutics, Inc: other filings, last Jun 20, 2024
  • LIFE aTYR PHARMA Inc: 10 buys, last May 8, 2019
  • EDIT Editas Medicine, Inc: other filings, last Jun 15, 2017

Get free alerts when John Mendlein files a new trade →